PrediabetesNCT07904962
Different Aerobic-to-Resistance Training Ratios in Adults Aged 50 Years and Older With Prediabetes
A study testing Combined Aerobic and Resistance Training (3:1), Combined Aerobic and Resistance Training (1:1) and Combined Aerobic and Resistance Training (1:3) in people with Prediabetes, run by China Institute of Sport Science at 1 site in China.
Trial summary
The goal of this clinical trial is to evaluate how different time ratios of aerobic and resistance training affect blood glucose levels and physical health in adults aged 50 years and older with prediabetes. Read more about this study
- Who is it for?
- Ages 50 years and older
- Conditions the study is for
- Prediabetes
- What is being tested?
- Combined Aerobic and Resistance Training (3:1), Combined Aerobic and Resistance Training (1:1) and Combined Aerobic and Resistance Training (1:3)
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 212 participants
- Where
- 1 siteChina
- Study dates
- Nov 2026to Jan 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age 50 years or older.
- Body mass index (BMI) of 24.0 to 32.5 kg/m².
- Prediabetes, defined by at least one of the following: fasting plasma glucose of 5.6-6.9 mmol/L, 2-hour plasma glucose of 7.8-11.0 mmol/L during a 75-g oral glucose tolerance test, or glycated hemoglobin (HbA1c) of 5.7%-6.4%, without meeting diagnostic criteria for diabetes.
- Not regularly meeting recommended exercise levels during the previous 3 months, defined as less than 150 minutes per week of moderate-intensity aerobic activity or an equivalent amount of moderate-to-vigorous aerobic activity, and resistance training on fewer than 2 days per week.
- Able to perform activities of daily living independently and considered medically suitable to participate safely in moderate-intensity aerobic and resistance exercise.
- Able to participate in the 12-week intervention and major study assessments.
- Able to understand the study procedures and provide written informed consent.
Who cannot join
- Previously diagnosed diabetes, or diabetes-range glucose results at formal baseline screening confirmed by medical assessment.
- Regular use within the previous 3 months of medications that may substantially affect glucose metabolism, body weight, or the primary outcome, including glucose-lowering medications, weight-loss medications, or systemic glucocorticoids.
- Severe, acute, or inadequately controlled medical conditions that, in the judgment of the study medical team, would make exercise participation or exercise testing unsafe.
- Severe musculoskeletal, neurological, cognitive, or psychiatric conditions that would interfere with safe participation in the intervention or study assessments.
- Alcohol Use Disorders Identification Test (AUDIT) score ≥16, or clinically significant harmful alcohol use or alcohol dependence based on medical assessment.
- Unintentional body weight change greater than 5% during the previous 6 months, or current participation in another structured intervention likely to substantially affect glucose metabolism, body weight, or physical activity.
- Pregnancy, breastfeeding, planned pregnancy during the study period, or other circumstances expected to prevent completion of the 12-week intervention and primary outcome assessment.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
China1 site
Jining Exercise and Health Promotion Center
Jining, Shandong
Ming He, +86 15688833099, sdtyrh@shandong.cn
About this study
Official title: Effects of Different Aerobic-to-Resistance Training Time Ratios in Adults Aged 50 Years and Older With Prediabetes: A Randomized Controlled Trial
The goal of this clinical trial is to evaluate how different time ratios of aerobic and resistance training affect blood glucose levels and physical health in adults aged 50 years and older with prediabetes. Researchers will compare three combined exercise programs with aerobic-to-resistance training time ratios of 3:1, 1:1, and 1:3 with a health education control group.
Participants in the exercise groups will take part in supervised training three times per week for 12 weeks. Each session will include approximately 60 minutes of aerobic and resistance exercise, with the amount of time spent on each type of exercise differing according to the assigned group. Participants will complete health assessments before and after the 12-week intervention. The main outcome of interest is glycated hemoglobin (HbA1c), which reflects average blood glucose levels over the previous 2 to 3 months. Participants in the control group will receive standardized health education and will not take part in the study-provided structured exercise program during the 12-week intervention period.
Read the detailed description
Prediabetes is a high-risk metabolic state associated with an increased likelihood of developing type 2 diabetes and other cardiometabolic complications. Both aerobic and resistance exercise can improve glucose regulation and metabolic health, but there is limited evidence regarding how the relative amounts of aerobic and resistance training should be combined when the overall training duration is kept similar. This study is designed to compare different aerobic-to-resistance training time ratios while maintaining a broadly comparable overall exercise duration across the exercise groups.
This is a prospective, four-arm, parallel-group randomized controlled trial. A total of 212 adults aged 50 years and older with prediabetes are planned to be randomly assigned in a 1:1:1:1 ratio to one of three combined aerobic and resistance training groups or to a health education control group. The three exercise groups will use aerobic-to-resistance training time ratios of 3:1, 1:1, and 1:3.
Participants assigned to the exercise groups will complete supervised training three times per week for 12 weeks. Each session will include approximately 60 minutes of main exercise training. The 3:1 group will complete approximately 45 minutes of aerobic exercise and 15 minutes of resistance training, the 1:1 group will complete approximately 30 minutes of each, and the 1:3 group will complete approximately 15 minutes of aerobic exercise and 45 minutes of resistance training. Aerobic training will consist of a standardized low-impact aerobic exercise routine. Resistance training will include standardized exercises targeting major muscle groups. Exercise intensity, resistance, and exercise difficulty will be progressively adjusted according to predefined training principles, safety considerations, and individual tolerance.
All study groups will receive standardized general health education. The control group will continue usual medical and community care and will not receive the study-provided structured aerobic and resistance exercise program during the 12-week intervention period.
Randomization will occur after completion of baseline assessments and confirmation of eligibility. Because of the nature of the exercise intervention, participants and exercise instructors cannot be masked to group assignment. Laboratory samples will be identified using coded study numbers without information on intervention assignment.
Study assessments will be conducted at baseline and after the 12-week intervention, with an additional follow-up planned approximately 12 weeks after completion of the intervention to explore the maintenance of selected effects. Assessments include measures of glucose regulation, body composition, physical performance, muscle strength, functional exercise capacity, physical activity, and selected metabolic measures. Continuous glucose monitoring and some additional mechanistic assessments will be conducted in prespecified exploratory components of the study.
- Conditions
- Prediabetes
- Being tested
- Combined Aerobic and Resistance Training (3:1), Combined Aerobic and Resistance Training (1:1), Combined Aerobic and Resistance Training (1:3), Standardized Health Education
- Keywords
- Aerobic exercise, Resistance training, Combined exercise, Exercise training, Glycated hemoglobin, Older adults
- Medical subject headings
- Prediabetic State
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Combined Aerobic and Resistance Training (3:1)Behavioural
Participants will complete 12 weeks of supervised combined aerobic and resistance training, three sessions per week. Each session will include approximately 60 minutes of main training, consisting of approximately 45 minutes of a standardized low-impact aerobic exercise routine and 15 minutes of resistance training. Training intensity and exercise difficulty will be progressively adjusted according to predefined safety criteria and individual tolerance.
Combined Aerobic and Resistance Training (1:1)Behavioural
Participants will complete 12 weeks of supervised combined aerobic and resistance training, three sessions per week. Each session will include approximately 60 minutes of main training, consisting of approximately 30 minutes of a standardized low-impact aerobic exercise routine and 30 minutes of resistance training. Training intensity and exercise difficulty will be progressively adjusted according to predefined safety criteria and individual tolerance.
Combined Aerobic and Resistance Training (1:3)Behavioural
Participants will complete 12 weeks of supervised combined aerobic and resistance training, three sessions per week. Each session will include approximately 60 minutes of main training, consisting of approximately 15 minutes of a standardized low-impact aerobic exercise routine and 45 minutes of resistance training. Training intensity and exercise difficulty will be progressively adjusted according to predefined safety criteria and individual tolerance.
Standardized Health EducationBehavioural
Participants will receive standardized health education during the 12-week intervention period. The education will provide general information on prediabetes, healthy lifestyles, sleep, smoking and alcohol use, medication adherence, and health and safety. It will not include an individualized structured exercise program or an individualized weight-loss diet prescription.
| Study group | Role | What they receive |
|---|---|---|
| Aerobic-to-Resistance 3:1 Training | Experimental | Participants will receive 12 weeks of supervised combined aerobic and resistance training, three sessions per week. Each session will include approximately 60 minutes of main training, consisting of approximately 45 minutes of aerobic training and 15 minutes of resistance training. Participants will also receive the standardized health education provided to all study groups. Receives: Behavioral: Combined Aerobic and Resistance Training (3:1) |
| Aerobic-to-Resistance 1:1 Training | Experimental | Participants will receive 12 weeks of supervised combined aerobic and resistance training, three sessions per week. Each session will include approximately 60 minutes of main training, consisting of approximately 30 minutes of aerobic training and 30 minutes of resistance training. Participants will also receive the standardized health education provided to all study groups. Receives: Behavioral: Combined Aerobic and Resistance Training (1:1) |
| Aerobic-to-Resistance 1:3 Training | Experimental | Participants will receive 12 weeks of supervised combined aerobic and resistance training, three sessions per week. Each session will include approximately 60 minutes of main training, consisting of approximately 15 minutes of aerobic training and 45 minutes of resistance training. Participants will also receive the standardized health education provided to all study groups. Receives: Behavioral: Combined Aerobic and Resistance Training (1:3) |
| Health Education Control | Active comparator | Participants will receive standardized health education and continue their usual medical and community care during the 12-week intervention period. They will not receive the study-provided structured aerobic or resistance exercise program during this period. Receives: Behavioral: Standardized Health Education |
What is being measured
The primary outcome is the main question the study is designed to answer.
Glycated Hemoglobin (HbA1c) at Week 12
Glycated Hemoglobin (HbA1c) will be measured from a venous blood sample and reported as a percentage (%). The primary comparison will evaluate HbA1c at Week 12 between the randomized groups, with baseline HbA1c accounted for in the primary statistical analysis.
Measured: Week 12
Secondary outcomes (5)
Fasting Plasma Glucose at Week 12
Fasting plasma glucose will be measured from a venous blood sample after an overnight fast and reported in mmol/L.
Measured: Week 12
2-Hour Plasma Glucose During the Oral Glucose Tolerance Test at Week 12
Plasma glucose will be measured 120 minutes after ingestion of a 75-g oral glucose load and reported in mmol/L.
Measured: Week 12
Normal Glucose Regulation at Week 12
Normal glucose regulation will be defined as meeting all of the following criteria at Week 12: fasting plasma glucose <5.6 mmol/L, 2-hour plasma glucose <7.8 mmol/L during a 75-g oral glucose tolerance test, and glycated hemoglobin (HbA1c) <5.7%. The outcome will be reported as the number and proportion of participants meeting these criteria.
Measured: Week 12
Total Body Fat Percentage at Week 12
Total body fat percentage will be assessed using dual-energy X-ray absorptiometry (DXA) and reported as a percentage (%).
Measured: Week 12
Short Physical Performance Battery Total Score at Week 12
Physical performance will be assessed using the Short Physical Performance Battery (SPPB), which includes standing balance, usual 4-meter walking speed, and five repeated chair stands. The total score ranges from 0 to 12 points, with higher scores indicating better physical performance.
Measured: Week 12
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Oct 2026
- Study startNov 2026 (estimated)
- Primary completionOct 2027 (estimated)
- Study completionJan 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PrediabetesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 212 participants (estimated)
Sponsor and investigators
- Lead sponsor
- China Institute of Sport Science
- Sponsor type
- Other government
- Responsible party
- Sponsor
- Investigators
- Qi Meng, Principal investigator, China Institute of Sport ScienceFeng Qiang, PhD, Study director, China Institute of Sport Science
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07904962
- Sponsor's protocol ID
- CISSLA-20260714
- Other IDs
- Project 26-05, Project 25-14
- Status last verified
- Oct 2026
- First submitted
- 23 Oct 2026
- Last updated
- 3 Nov 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Different Aerobic-to-Resistance Training Time Ratios in Adults Aged 50 Years and Older With Prediabetes: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07904962
- Acronym / sponsor ID
- CISSLA-20260714
- Conditions
- Prediabetes
- Keywords
- Aerobic exercise, Resistance training, Combined exercise, Exercise training, Glycated hemoglobin, Older adults
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 212 participants (estimated)
- Lead sponsor
- China Institute of Sport ScienceOther government
- Study start
- Nov 2026 (estimated)
- Primary completion
- Oct 2027 (estimated)
- Study completion
- Jan 2028 (estimated)
- First posted
- 29 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to evaluate how different time ratios of aerobic and resistance training affect blood glucose levels and physical health in adults aged 50 years and older with prediabetes. Researchers will compare three combined exercise programs with aerobic-to-resistance training time ratios of 3:1, 1:1, and 1:3 with a health education control group.
Participants in the exercise groups will take part in supervised training three times per week for 12 weeks. Each session will include approximately 60 minutes of aerobic and resistance exercise, with the amount of time spent on each type of exercise differing according to the assigned group. Participants will complete health assessments before and after the 12-week intervention. The main outcome of interest is glycated hemoglobin (HbA1c), which reflects average blood glucose levels over the previous 2 to 3 months. Participants in the control group will receive standardized health education and will not take part in the study-provided structured exercise program during the 12-week intervention period.
Detailed description
Prediabetes is a high-risk metabolic state associated with an increased likelihood of developing type 2 diabetes and other cardiometabolic complications. Both aerobic and resistance exercise can improve glucose regulation and metabolic health, but there is limited evidence regarding how the relative amounts of aerobic and resistance training should be combined when the overall training duration is kept similar. This study is designed to compare different aerobic-to-resistance training time ratios while maintaining a broadly comparable overall exercise duration across the exercise groups.
This is a prospective, four-arm, parallel-group randomized controlled trial. A total of 212 adults aged 50 years and older with prediabetes are planned to be randomly assigned in a 1:1:1:1 ratio to one of three combined aerobic and resistance training groups or to a health education control group. The three exercise groups will use aerobic-to-resistance training time ratios of 3:1, 1:1, and 1:3.
Participants assigned to the exercise groups will complete supervised training three times per week for 12 weeks. Each session will include approximately 60 minutes of main exercise training. The 3:1 group will complete approximately 45 minutes of aerobic exercise and 15 minutes of resistance training, the 1:1 group will complete approximately 30 minutes of each, and the 1:3 group will complete approximately 15 minutes of aerobic exercise and 45 minutes of resistance training. Aerobic training will consist of a standardized low-impact aerobic exercise routine. Resistance training will include standardized exercises targeting major muscle groups. Exercise intensity, resistance, and exercise difficulty will be progressively adjusted according to predefined training principles, safety considerations, and individual tolerance.
All study groups will receive standardized general health education. The control group will continue usual medical and community care and will not receive the study-provided structured aerobic and resistance exercise program during the 12-week intervention period.
Randomization will occur after completion of baseline assessments and confirmation of eligibility. Because of the nature of the exercise intervention, participants and exercise instructors cannot be masked to group assignment. Laboratory samples will be identified using coded study numbers without information on intervention assignment.
Study assessments will be conducted at baseline and after the 12-week intervention, with an additional follow-up planned approximately 12 weeks after completion of the intervention to explore the maintenance of selected effects. Assessments include measures of glucose regulation, body composition, physical performance, muscle strength, functional exercise capacity, physical activity, and selected metabolic measures. Continuous glucose monitoring and some additional mechanistic assessments will be conducted in prespecified exploratory components of the study.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Aerobic-to-Resistance 3:1 Training | Experimental | Behavioral: Combined Aerobic and Resistance Training (3:1)Participants will receive 12 weeks of supervised combined aerobic and resistance training, three sessions per week. Each session will include approximately 60 minutes of main training, consisting of approximately 45 minutes of aerobic training and 15 minutes of resistance training. Participants will also receive the standardized health education provided to all study groups. |
| Aerobic-to-Resistance 1:1 Training | Experimental | Behavioral: Combined Aerobic and Resistance Training (1:1)Participants will receive 12 weeks of supervised combined aerobic and resistance training, three sessions per week. Each session will include approximately 60 minutes of main training, consisting of approximately 30 minutes of aerobic training and 30 minutes of resistance training. Participants will also receive the standardized health education provided to all study groups. |
| Aerobic-to-Resistance 1:3 Training | Experimental | Behavioral: Combined Aerobic and Resistance Training (1:3)Participants will receive 12 weeks of supervised combined aerobic and resistance training, three sessions per week. Each session will include approximately 60 minutes of main training, consisting of approximately 15 minutes of aerobic training and 45 minutes of resistance training. Participants will also receive the standardized health education provided to all study groups. |
| Health Education Control | Active comparator | Behavioral: Standardized Health EducationParticipants will receive standardized health education and continue their usual medical and community care during the 12-week intervention period. They will not receive the study-provided structured aerobic or resistance exercise program during this period. |
Who may qualify
- Ages
- 50 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Age 50 years or older.
- Body mass index (BMI) of 24.0 to 32.5 kg/m².
- Prediabetes, defined by at least one of the following: fasting plasma glucose of 5.6-6.9 mmol/L, 2-hour plasma glucose of 7.8-11.0 mmol/L during a 75-g oral glucose tolerance test, or glycated hemoglobin (HbA1c) of 5.7%-6.4%, without meeting diagnostic criteria for diabetes.
- Not regularly meeting recommended exercise levels during the previous 3 months, defined as less than 150 minutes per week of moderate-intensity aerobic activity or an equivalent amount of moderate-to-vigorous aerobic activity, and resistance training on fewer than 2 days per week.
- Able to perform activities of daily living independently and considered medically suitable to participate safely in moderate-intensity aerobic and resistance exercise.
Key exclusion criteria (7 listed)
- Previously diagnosed diabetes, or diabetes-range glucose results at formal baseline screening confirmed by medical assessment.
- Regular use within the previous 3 months of medications that may substantially affect glucose metabolism, body weight, or the primary outcome, including glucose-lowering medications, weight-loss medications, or systemic glucocorticoids.
- Severe, acute, or inadequately controlled medical conditions that, in the judgment of the study medical team, would make exercise participation or exercise testing unsafe.
- Severe musculoskeletal, neurological, cognitive, or psychiatric conditions that would interfere with safe participation in the intervention or study assessments.
- Alcohol Use Disorders Identification Test (AUDIT) score ≥16, or clinically significant harmful alcohol use or alcohol dependence based on medical assessment.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Combined Aerobic and Resistance Training (3:1)Participants will complete 12 weeks of supervised combined aerobic and resistance training, three sessions per week. Each session will include approximately 60 minutes of main training, consisting of approximately 45 minutes of a standardized low-impact aerobic exercise routine and 15 minutes of resistance training. Training intensity and exercise difficulty will be progressively adjusted according to predefined safety criteria and individual tolerance. | Behavioural | Aerobic-to-Resistance 3:1 Training |
| Combined Aerobic and Resistance Training (1:1)Participants will complete 12 weeks of supervised combined aerobic and resistance training, three sessions per week. Each session will include approximately 60 minutes of main training, consisting of approximately 30 minutes of a standardized low-impact aerobic exercise routine and 30 minutes of resistance training. Training intensity and exercise difficulty will be progressively adjusted according to predefined safety criteria and individual tolerance. | Behavioural | Aerobic-to-Resistance 1:1 Training |
| Combined Aerobic and Resistance Training (1:3)Participants will complete 12 weeks of supervised combined aerobic and resistance training, three sessions per week. Each session will include approximately 60 minutes of main training, consisting of approximately 15 minutes of a standardized low-impact aerobic exercise routine and 45 minutes of resistance training. Training intensity and exercise difficulty will be progressively adjusted according to predefined safety criteria and individual tolerance. | Behavioural | Aerobic-to-Resistance 1:3 Training |
| Standardized Health EducationParticipants will receive standardized health education during the 12-week intervention period. The education will provide general information on prediabetes, healthy lifestyles, sleep, smoking and alcohol use, medication adherence, and health and safety. It will not include an individualized structured exercise program or an individualized weight-loss diet prescription. | Behavioural | Health Education Control |
Primary outcome
Glycated Hemoglobin (HbA1c) at Week 12
Time frame: Week 12
Glycated Hemoglobin (HbA1c) will be measured from a venous blood sample and reported as a percentage (%). The primary comparison will evaluate HbA1c at Week 12 between the randomized groups, with baseline HbA1c accounted for in the primary statistical analysis.
5 secondary outcomes
Fasting Plasma Glucose at Week 12
Time frame: Week 12
2-Hour Plasma Glucose During the Oral Glucose Tolerance Test at Week 12
Time frame: Week 12
Normal Glucose Regulation at Week 12
Time frame: Week 12
Total Body Fat Percentage at Week 12
Time frame: Week 12
Short Physical Performance Battery Total Score at Week 12
Time frame: Week 12
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Nov 2026.
- Individual participant dataSharing planned: No
Related trials for Prediabetes
Recruiting
Effects of Lean Pork Loin Intake on Protein Homeostasis and Glucose Regulation in Prediabetic Adults
Hyperglycaemia (Non Diabetic), Prediabetes
RecruitingObservational study
Food-i-Sense Analytics: Integrating AI Into Continuous Glucose Monitoring Data Analysis for Precision Nutrition.
Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Artificial Intelligence Mobile Application
RecruitingPhase 3
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Overweight, Prediabetic State
Enrolling by invitationEarly Phase 1
Truway Diagnostic Tools in Primary Care
Chronic Disease, Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Recruiting
CGM-Enhanced DPP to Prevent Type 2 Diabetes in Adults With Prediabetes
PreDiabetes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Qi Meng principal investigator
China Institute of Sport Science
Feng Qiang, PhD study director
China Institute of Sport Science
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Combined Aerobic and Resistance Training (3:1), Combined Aerobic and Resistance Training (1:1) and Combined Aerobic and Resistance Training (1:3) in people with Prediabetes, run by China Institute of Sport Science at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 3 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Qi Meng (+86 17852650582, mengqi@ciss.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Glycated Hemoglobin (HbA1c) at Week 12 (time frame: Week 12). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2026.